1. Home
  2. CERS vs MIN Comparison

CERS vs MIN Comparison

Compare CERS & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • MIN
  • Stock Information
  • Founded
  • CERS 1991
  • MIN 1988
  • Country
  • CERS United States
  • MIN United States
  • Employees
  • CERS N/A
  • MIN N/A
  • Industry
  • CERS EDP Services
  • MIN Trusts Except Educational Religious and Charitable
  • Sector
  • CERS Technology
  • MIN Finance
  • Exchange
  • CERS Nasdaq
  • MIN Nasdaq
  • Market Cap
  • CERS 286.0M
  • MIN 306.7M
  • IPO Year
  • CERS 1997
  • MIN N/A
  • Fundamental
  • Price
  • CERS $1.83
  • MIN $2.67
  • Analyst Decision
  • CERS Buy
  • MIN
  • Analyst Count
  • CERS 3
  • MIN 0
  • Target Price
  • CERS $3.17
  • MIN N/A
  • AVG Volume (30 Days)
  • CERS 1.4M
  • MIN 331.0K
  • Earning Date
  • CERS 03-04-2025
  • MIN 01-01-0001
  • Dividend Yield
  • CERS N/A
  • MIN 7.31%
  • EPS Growth
  • CERS N/A
  • MIN N/A
  • EPS
  • CERS N/A
  • MIN 0.08
  • Revenue
  • CERS $176,229,000.00
  • MIN N/A
  • Revenue This Year
  • CERS $21.42
  • MIN N/A
  • Revenue Next Year
  • CERS $11.12
  • MIN N/A
  • P/E Ratio
  • CERS N/A
  • MIN $33.38
  • Revenue Growth
  • CERS 14.71
  • MIN N/A
  • 52 Week Low
  • CERS $1.38
  • MIN $2.52
  • 52 Week High
  • CERS $2.59
  • MIN $2.88
  • Technical
  • Relative Strength Index (RSI)
  • CERS 60.59
  • MIN 49.70
  • Support Level
  • CERS $1.74
  • MIN $2.63
  • Resistance Level
  • CERS $1.89
  • MIN $2.67
  • Average True Range (ATR)
  • CERS 0.10
  • MIN 0.03
  • MACD
  • CERS 0.03
  • MIN 0.00
  • Stochastic Oscillator
  • CERS 89.74
  • MIN 61.11

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About MIN MFS Intermediate Income Trust

MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.

Share on Social Networks: